Maverick - 11/27/10 3:45 am
Letter from Histogen.
“Thank you for your interest and message.
Histogen’s Hair Stimulating Complex (HSC) is currently in clinical trials as an injectable for hair regrowth in Male Pattern Hair Loss. More information, and the latest news from our pilot clinical trial of HSC, can be found on the news section of our website at: http://www.histogen.com/aboutus/news_events.htm#25.
Our next clinical trial is scheduled to begin in early 2011 in Singapore. While we don’t expect our product to be launched in the US until the 2015 timeframe, Histogen hopes that we can launch sooner outside the US if our international trials go well. However, that timeframe would also be a few years out. As an estimation, Histogen hopes to get product approval in Asia by mid-2013. Histogen expects that launching the HSC product in the EU will be around the same time as a US product in 2015. As the product progresses through development, Histogen will identify whether trials in the UK/EU are necessary.
As for hair loss in women, the Histogen team and hair specialists we work with believe that our product should work in women. While these initial studies are focused on male pattern hair loss, Histogen is considering a small side study for hair loss in women and diffused hair loss.
If I can answer any further questions, please feel free to contact me directly at the email below.
Thomas L Hubka
ReGenica Brand Manager”
Thanks to @Maverick!